Myriad Genetics, Inc. Being Investigated on Behalf of Myriad Genetics, Inc. Investors. Contact Levi & Korsinsky For Details
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Myriad Genetics, Inc. for potential violations of federal securities laws. This follows UnitedHealth Group's decision to stop covering Myriad's GeneSight test starting January 1, 2025.
November 14, 2024 | 3:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Myriad Genetics is under investigation for potential securities law violations after UnitedHealth announced it will stop covering the GeneSight test.
The investigation into Myriad Genetics for potential securities law violations, combined with the loss of coverage for its GeneSight test by UnitedHealth, is likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100